Form 4: Health Catalyst Director Julie Larson-Green Receives Significant RSU Grant

Health Catalyst, Inc. director Julie Larson-Green was granted 36,231 restricted stock units, increasing her beneficial ownership to 111,251 shares.

Summary

• Julie Larson-Green, a Director of Health Catalyst, Inc. (HCAT), acquired 36,231 shares of common stock through a Restricted Stock Unit (RSU) award.
• The transaction date for this acquisition was July 9, 2025.
• The acquisition price for these RSUs was $0.00 per share, as they represent a contingent right to receive shares.
• Following this transaction, Julie Larson-Green beneficially owns a total of 111,251 shares of Health Catalyst common stock directly.
• The RSUs were granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan.
• Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Sentiment

Score: 6

Explanation: The document reports a routine insider transaction related to director compensation, which is generally a neutral to slightly positive event as it aligns director interests with shareholders. It does not contain information that would significantly alter the company's financial outlook or operations.

Positives

• The grant of Restricted Stock Units to a director aligns their interests with those of shareholders, incentivizing long-term performance and value creation.
• The award is part of the Issuer's established 2019 Stock Option and Incentive Plan, indicating a structured approach to executive and director compensation.

Future Outlook

The granted Restricted Stock Units are set to fully vest on the earlier of the one-year anniversary of the grant date (July 9, 2026) or the date of the next Annual Meeting of the Issuer's Stockholders, contingent on the terms of the 2019 Plan.

Industry Context

The grant of Restricted Stock Units to a director is a common practice in the technology and healthcare technology sectors for executive and director compensation, aiming to align leadership incentives with long-term company performance and shareholder value.

Related Party Transactions

• The RSU grant to Julie Larson-Green, a director of Health Catalyst, Inc., constitutes a related party transaction as it involves compensation to an insider.

Stakeholder Impact

• Shareholders: The RSU grant aligns the director's financial interests with long-term shareholder value, potentially leading to more focused decision-making aimed at increasing stock price.
• Employees: While not directly impacting general employees, such compensation structures for leadership can set a precedent for performance-based incentives within the company.
• Director (Julie Larson-Green): Receives a significant equity award, providing a direct financial incentive tied to the company's future performance.

Next Steps

• The Restricted Stock Units will proceed towards vesting on the earlier of July 9, 2026, or the date of the next Annual Meeting of Health Catalyst's Stockholders, subject to the terms of the 2019 Plan.

Key Dates

Keywords

Health Catalyst, HCAT, SEC Form 4, Restricted Stock Units, RSU, Insider Transaction, Director Compensation, Equity Award, Stock Grant